Medicinal Cannabis Matters: Friday Roundup - 21 November 2025

England Announces First-Ever Men’s Health Strategy

The government has set out England’s first dedicated Men’s Health Strategy, a long-awaited move aimed at addressing rising concerns around preventable illness, mental health, chronic pain and barriers to treatment.

The strategy recognises that men are often less likely to seek help early, particularly for conditions linked to chronic pain, stress, anxiety and sleep disorders, all areas where medicinal cannabis, when clinically appropriate, can offer an alternative approach to traditional treatments.

At Medicann, we see first-hand how many male patients delay seeking support, often relying on painkillers for far longer than they should. A national focus on earlier intervention and more personalised care is an important step forward.

How Chronic Pain Reshapes Everyday Life

A recent report by the BBC highlights the lived experiences of patients whose daily lives are heavily affected by persistent pain, and the emotional, physical and social challenges that come with it.

The article sheds light on a common theme: these patients are often offered limited long-term treatment options, with some relying on medication that leaves them fatigued, sedated or struggling to function. 

For many of our patients at Medicann, turning to medicinal cannabis has provided a more balanced way of managing symptoms; helping to ease pain while allowing them to stay clear-headed and more engaged in daily life.

Although every patient’s experience is unique, stories like these show a widening recognition that pain management must evolve beyond traditional painkillers alone.

Medicann Ahead of The Curve For Trained Prescribers

A new report from Cannabis Health News reveals that fewer than 1% of UK doctors are currently trained to prescribe medicinal cannabis, highlighting a nationwide gap in clinical education and access.

This shortage underlines the importance of specialist clinics, like Medicann, that prioritise proper training, responsible prescribing and consistent patient support.

At Medicann, our prescribing doctors undergo dedicated training, ensuring that every patient receives safe, evidence-based care from clinicians who truly understand how these treatments work. We have long recognised the need for expertise in this area, and we continue to invest in clinical development so our teams remain at the forefront of best practice.

As the national conversation grows, reports like this reinforce just how vital experienced, well-trained prescribers are, and why specialist clinics play such a key role in helping patients access the treatment they need.

Free Doctor-Led Advice Sessions This Month

Medicann is pleased to support Medicinal Cannabis Awareness Month, an initiative dedicated to improving understanding, addressing misconceptions and expanding safe access for patients who could benefit.

Throughout November, we are spotlighting the progress, evidence and patient experiences that continue to shape medicinal cannabis care across the UK and Channel Islands. 

To mark the month, our clinical teams across Guernsey, Jersey and the Isle of Man are offering free weekly sessions to support patients who want to learn more about medicinal cannabis and whether it may be suitable for their condition. See below for clinic times relating to your location:

Medicann Guernsey

Every Tuesday, 5-6pm

Medicann Jersey

Every Wednesday, 5-6pm

Medicann Isle of Man

Every Thursday, 5-6pm

These sessions are led by experienced prescribing doctors who can answer questions, offer clinical guidance and provide clarity on treatment options.

If you’re considering treatment, our free Eligibility Checker is a quick, confidential way to find out whether you may qualify for medicinal cannabis. It takes less than two minutes to complete and can help you understand your next steps.

Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.